Peter Barclay

637 total citations
16 papers, 413 citations indexed

About

Peter Barclay is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Peter Barclay has authored 16 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Surgery. Recurrent topics in Peter Barclay's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmaceutical studies and practices (4 papers) and Patient Safety and Medication Errors (3 papers). Peter Barclay is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmaceutical studies and practices (4 papers) and Patient Safety and Medication Errors (3 papers). Peter Barclay collaborates with scholars based in Australia, Italy and Philippines. Peter Barclay's co-authors include Jonathan C. Craig, Kathy Kable, Cheryl Jones, Giovanni FM Strippoli, Dushyanthi Vimalachandra, Elisabeth M Hodson, Angela C Webster, David C.H. Harris, Beata Bajorek and Michelle A. Farrar and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Archives of Disease in Childhood.

In The Last Decade

Peter Barclay

13 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Barclay Australia	8	240	65	64	57	56	16	413
Hugo Wéclawiak France	12	176 0.7×	52 0.8×	42 0.7×	16 0.3×	167 3.0×	21	506
Aykut Sifil Türkiye	11	97 0.4×	57 0.9×	13 0.2×	52 0.9×	36 0.6×	36	330
Ian Dittmer New Zealand	10	208 0.9×	114 1.8×	58 0.9×	37 0.6×	89 1.6×	29	553
A. Famulari Italy	12	142 0.6×	140 2.2×	49 0.8×	26 0.5×	39 0.7×	55	423
Isabelle Cardeau‐Desangles France	16	234 1.0×	243 3.7×	55 0.9×	57 1.0×	323 5.8×	24	1.0k
HR Brodt Germany	8	201 0.8×	43 0.7×	94 1.5×	9 0.2×	392 7.0×	11	619
Julien Coussement Belgium	12	224 0.9×	63 1.0×	55 0.9×	12 0.2×	105 1.9×	22	441
Lúcio Requião‐Moura Brazil	12	62 0.3×	87 1.3×	29 0.5×	32 0.6×	50 0.9×	51	361
Varun Saxena United States	16	606 2.5×	89 1.4×	15 0.2×	18 0.3×	112 2.0×	35	941
Sofía Zárraga Spain	11	76 0.3×	53 0.8×	69 1.1×	46 0.8×	155 2.8×	33	395

Countries citing papers authored by Peter Barclay

Since Specialization

Citations

This map shows the geographic impact of Peter Barclay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Barclay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Barclay more than expected).

Fields of papers citing papers by Peter Barclay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Barclay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Barclay. The network helps show where Peter Barclay may publish in the future.

Co-authorship network of co-authors of Peter Barclay

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Barclay. A scholar is included among the top collaborators of Peter Barclay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Barclay. Peter Barclay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Raban, Magdalena Z., Tim Badgery‐Parker, Ling Li, et al.. (2024). Longitudinal study of the manifestations and mechanisms of technology-related prescribing errors in pediatrics. Journal of the American Medical Informatics Association. 32(1). 105–112.

Mumford, Virginia, Magdalena Z. Raban, Ling Li, et al.. (2024). Developing a process to measure actual harm from medication errors in paediatric inpatients: From design to implementation. British Journal of Clinical Pharmacology. 90(7). 1615–1626. 1 indexed citations

Hanrahan, Jane R., et al.. (2024). Surface contamination of cytotoxic medicine in preparation and patient care areas in Australian hospitals: a retrospective cross‐sectional study. Journal of Pharmacy Practice and Research. 54(4). 306–313.

Farrar, Michelle A., et al.. (2023). Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective. SHILAP Revista de lepidopterología. 10(1). 17–17. 2 indexed citations

D’Silva, Arlene, Didu Kariyawasam, Peter Barclay, et al.. (2022). Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy. Annals of Clinical and Translational Neurology. 9(3). 339–350. 46 indexed citations

Barclay, Peter. (2021). A grammar of Western Dani. Open MIND.

Westbrook, Johanna, Ling Li, Magdalena Z. Raban, et al.. (2020). Associations between double-checking and medication administration errors: a direct observational study of paediatric inpatients. BMJ Quality & Safety. 30(4). 320–330. 28 indexed citations

Barclay, Peter, et al.. (2016). Hospital pharmacists’ perspectives on the role of key performance indicators in Australian pharmacy practice. Journal of Pharmacy Practice and Research. 47(2). 87–95. 11 indexed citations

Bajorek, Beata, et al.. (2015). Narrative review: status of key performance indicators in contemporary hospital pharmacy practice. Journal of Pharmacy Practice and Research. 45(4). 396–403. 7 indexed citations

10.

Sinha, Yashwant, Jonathan C. Craig, Peter Barclay, et al.. (2014). A national study of the processes and outcomes of paediatric formulary applications in Australia. The Medical Journal of Australia. 200(9). 541–545. 3 indexed citations

11.

Sinha, Yashwant, Jonathan C. Craig, Peter Barclay, et al.. (2010). Drug approval processes in Australian Paediatric Hospitals. Archives of Disease in Childhood. 95(9). 739–744. 3 indexed citations

12.

Sharma, Raghwa, et al.. (2007). Evaluation of the off‐label usage of rituximab in a large teaching hospital in New South Wales. Internal Medicine Journal. 37(8). 569–571. 8 indexed citations

13.

Hodson, Elisabeth M, Cheryl Jones, Angela C Webster, et al.. (2005). Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. The Lancet. 365(9477). 2105–2115. 264 indexed citations

14.

Nankivell, Brian J., M.A. Malouf, Graeme R. Russ, et al.. (1998). Maintenance therapy with oral ganciclovir after treatment of cytomegalovirus infection. Clinical Transplantation. 12(3). 270–273. 13 indexed citations

15.

Barclay, Peter, et al.. (1993). Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.. PubMed. 40(5). 277–80. 14 indexed citations

16.

Barclay, Peter, R. Allen, John H. Stewart, Kar Hui Ng, & Jeremy R. Chapman. (1992). Costs of immunosuppressive therapies used in renal transplantation.. PubMed. 24(1). 165–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact